BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 10421226)

  • 21. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats.
    Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS
    J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin secretion by perfused islets from the obese Zucker rat.
    Schade S; Eaton RP
    Proc Soc Exp Biol Med; 1975 Jun; 149(2):311-4. PubMed ID: 1098049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
    Zhou YP; Berggren PO; Grill V
    Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
    Alemzadeh R; Tushaus K
    Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats.
    Tang J; Pugh W; Polonsky KS; Zhang H
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E504-12. PubMed ID: 8638699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically obese rats with (SHR/N-cp) and without diabetes (LA/N-cp) share abnormal islet responses to glucose.
    Timmers KI; Voyles NR; Recant L
    Metabolism; 1992 Oct; 41(10):1125-33. PubMed ID: 1406299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats.
    Zawalich WS; Zawalich KC
    Endocrinology; 2000 Sep; 141(9):3287-95. PubMed ID: 10965900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y; Donahue EP; Shiota M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adrenalectomy on the development of a pancreatic islet lesion in fa/fa rats.
    Kibenge MT; Chan CB
    Diabetologia; 1996 Feb; 39(2):190-8. PubMed ID: 8635671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced insulin secretion and calcium uptake by Zucker "fatty" rat islets.
    Pansini AR; Tolman EL
    Horm Metab Res; 1981 Aug; 13(8):430-3. PubMed ID: 7035321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.
    Ahrén B; Magrum LJ; Havel PJ; Greene SF; Phinney SD; Johnson PR; Stern JS
    Obes Res; 2000 Sep; 8(6):475-80. PubMed ID: 11011915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.
    Janssen SW; Martens GJ; Sweep CG; Span PN; Verhofstad AA; Hermus AR
    J Endocrinol Invest; 2003 Jun; 26(6):508-15. PubMed ID: 12952363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
    Unger RH
    Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.
    Sreenan S; Keck S; Fuller T; Cockburn B; Burant CF
    Am J Physiol; 1999 Jun; 276(6):E1119-29. PubMed ID: 10362626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
    Jones HB; Nugent D; Jenkins R
    Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats.
    Liu YQ; Jetton TL; Leahy JL
    J Biol Chem; 2002 Oct; 277(42):39163-8. PubMed ID: 12147706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway.
    Thams P; Anwar MR; Capito K
    Eur J Endocrinol; 2005 Apr; 152(4):671-7. PubMed ID: 15817925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
    Shimabukuro M; Zhou YT; Levi M; Unger RH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.